Gelonghui on March 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of February 29, 2024, the company had repurchased 14,000,000 shares of the company's shares through a dedicated securities account, accounting for 1.00% of the company's current total share capital (1,399,938,234 shares). The highest transaction price of the repurchase was 6.78 yuan/share, and the minimum transaction price was RMB 5.18 yuan/share, and the total transaction amount was RMB 90,3236 million (excluding transaction fees).
仁和药业(000650.SZ)：已累计回购1.00%股份
Renhe Pharmaceutical (000650.SZ): 1.00% of shares have been cumulatively repurchased
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.